Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424111 · ClinicalTrials.gov registry record
Exploring Biomarkers for Depression
A clinical trial, sponsored by Wyss Institute at Harvard University.
- Completed
- Registry status
- 51
- Enrollment target
NCT01424111 is a clinical trial that has completed, run by Wyss Institute at Harvard University. The registered enrollment target is 51 participants.
The verdict
NCT01424111 has completed, sponsored by Wyss Institute at Harvard University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this research is to explore objective biomarkers in voice, physiological, motor, and brain imaging signals that may one day be used to complement clinical evaluation and treatment of depression.
Interventions
- DRUG Escitalopram
- OTHER Healthy Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-10-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01424111
The ClinicalTrials.gov registry entry for NCT01424111 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wyss Institute at Harvard University, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Escitalopram is the first listed.
NCT01424111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01424111 about?
NCT01424111 is a clinical study titled "Exploring Biomarkers for Depression". The purpose of this research is to explore objective biomarkers in voice, physiological, motor, and brain imaging signals that may one day be used to complement clinical evaluation and treatment of depression.
What is the current status of trial NCT01424111?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2011-08. Estimated completion is 2017-10-14.
What interventions are being tested in trial NCT01424111?
The interventions under investigation include: Escitalopram (DRUG), Healthy Control (OTHER).
Who is sponsoring clinical trial NCT01424111?
This trial is sponsored by Wyss Institute at Harvard University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.